azomycin has been researched along with melphalan in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (88.89) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bump, EA; Cerce, BA; Coleman, CN; McGinnis, DJ | 1 |
| Bubley, G; Coleman, CN; Eder, JP; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA | 1 |
| Gipp, JJ; McClelland, RA; Mulcahy, RT; Ublacker, GA | 1 |
| Hickson, ID; Robson, CN; Stephens, M; Stratford, IJ | 1 |
| Roizin-Towle, L | 1 |
| Noker, PE; Simpson-Herren, L; Wagoner, SD | 1 |
| Denekamp, J; Randhawa, VS; Stewart, FA; Stratford, MR | 1 |
| Hall, EJ; Roizin-Towle, LA | 1 |
| Hall, EJ; Miller, RC; Osmak, R; Zimmerman, M | 1 |
| Brown, JM | 1 |
| Biaglow, JE; Meltzer, HL; Roizin-Towle, L; Varnes, ME | 1 |
| Kehrberg, G; Moldenhauer, H; Rose, H; Saul, G; Wolf, G | 1 |
| Hinchliffe, M; McNally, NJ | 1 |
| Brown, JM; Hazlehurst, JL; Hirst, DG; Horsman, MR | 1 |
| McNally, NJ | 1 |
| Siemann, DW | 1 |
| Brown, JM; Evans, JW; Horsman, MR | 1 |
| Clarke, C; Dawson, KB; Sheldon, PW; Simmons, DJ; Simpson, W | 1 |
| Brown, JM; Hsu, B; Sawyer, JM; Taylor, YC | 1 |
| Maddison, K; Siemann, DW; Wolf, K | 1 |
| Hinchliffe, M; McNally, NJ; Stratford, MR | 1 |
| Meyn, RE; Murray, D | 1 |
| Jinks, S; Millar, BC | 1 |
| Brown, JM; Evans, JW; Taylor, YC | 1 |
| Twentyman, PR; Workman, P | 1 |
| de Ronde, J; Hinchliffe, M; McNally, NJ | 1 |
| Carter, SK; Coleman, CN; Friedman, MK; Gribble, M; Halsey, J; Hirst, VK; Ignoffo, R; Jacobs, C; Leibel, S; Phillips, TL | 1 |
| Twentyman, P; Workman, P | 1 |
| Clutterbuck, RD; McElwain, TJ; Millar, JL | 1 |
| Brown, JM; Hirst, DG | 1 |
| Adams, GE; Smith, E; Stratford, IJ | 1 |
| Adams, GE; Batten, EL; Sheldon, PW | 1 |
| Adams, GE; Horsman, MR; Kandaiya, S; Rajaratnam, S; Smith, E; Stratford, IJ; Williamson, C | 1 |
| De Ronde, J; Martin, WM; McNally, NJ | 1 |
| Catane, R; Clement, JJ; Gorman, MS; Johnson, RK; Wodinsky, I | 1 |
| Bloomer, WD; Ji, M; Papadopoulou, MV; Rao, MK | 1 |
2 review(s) available for azomycin and melphalan
| Article | Year |
|---|---|
[Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization].
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Chlorambucil; Cisplatin; Cricetinae; Cyclophosphamide; Doxorubicin; Etanidazole; Lomustine; Melphalan; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Modification of chemotherapy by nitroimidazoles.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; DNA Repair; Drug Synergism; Glutathione; Lomustine; Melphalan; Mice; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1984 |
34 other study(ies) available for azomycin and melphalan
| Article | Year |
|---|---|
Sensitization of Chinese hamster ovary cells to melphalan by etanidazole under intermittent hypoxia.
Topics: Animals; Cell Hypoxia; Cell Survival; CHO Cells; Cricetinae; Etanidazole; Melphalan; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1992 |
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carboplatin; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorocarbons; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Melphalan; Mice; Nitroimidazoles; Organoplatinum Compounds; Oxygen; Radiation-Sensitizing Agents; Thiotepa | 1991 |
Enhancement of melphalan (L-PAM) toxicity by reductive metabolites of 1-methyl-2-nitroimidazole, a model nitroimidazole chemosensitizing agent.
Topics: Buthionine Sulfoximine; Cell Survival; Drug Synergism; Glutathione; Humans; In Vitro Techniques; Melphalan; Methionine Sulfoximine; Nitroimidazoles; Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Etanidazole; Glutathione Transferase; Melphalan; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1989 |
Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
Topics: Animals; Buthionine Sulfoximine; Cells, Cultured; Cricetinae; Cricetulus; Drug Synergism; Etanidazole; Melphalan; Methionine Sulfoximine; Misonidazole; Nitroimidazoles; Oxygen; Sulfhydryl Compounds | 1985 |
Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.
Topics: Adenocarcinoma; Animals; Female; Lissamine Green Dyes; Mammary Neoplasms, Experimental; Melphalan; Metronidazole; Mice; Misonidazole; Nitroimidazoles; Time Factors | 1987 |
Factors influencing the chemosensitization of melphalan by misonidazole.
Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrosarcoma; Kinetics; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Temperature | 1985 |
Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cell Line; Cell Survival; Cisplatin; Cricetinae; Cricetulus; Drug Synergism; Melphalan; Misonidazole; Nitroimidazoles; Oxygen | 1981 |
Comparison of the incidence of oncogenic transformation produced by X rays, misonidazole, and chemotherapy agents.
Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Cisplatin; Doxorubicin; Fibroblasts; In Vitro Techniques; Melphalan; Mice; Misonidazole; Nitroimidazoles; Radiation, Ionizing; Vincristine; X-Rays | 1982 |
Clinical perspectives for the use of new hypoxic cell sensitizers.
Topics: Animals; Cyclophosphamide; Dogs; Drug Therapy, Combination; Etanidazole; Humans; Melphalan; Mice; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Solubility | 1982 |
Factors associated with the preincubation effect of hypoxic cell sensitizers in vitro and their possible implications in chemosensitization.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Cysteamine; Dose-Response Relationship, Drug; Drug Resistance; Etanidazole; Hydrogen Peroxide; Hyperthermia, Induced; Hypoxia; Melphalan; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Time Factors | 1984 |
A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Etanidazole; Fibrosarcoma; Melphalan; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
The effect of timing on chemosensitization by clinical levels of SR-2508.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Etanidazole; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1984 |
The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
Topics: Amifostine; Animals; Cell Survival; Cyclophosphamide; Drug Therapy, Combination; Leukopenia; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental | 1982 |
Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
Topics: Animals; Body Temperature; Cell Survival; Drug Synergism; Female; Kinetics; Melphalan; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Sarcoma, Experimental; Time Factors | 1984 |
Intestinal microflora as potential modifiers of sensitizer activity in vivo.
Topics: Animals; Bacteria; Body Temperature; Combined Modality Therapy; Drug Synergism; Female; Intestines; Lung Neoplasms; Melphalan; Mice; Misonidazole; Nitroimidazoles; Penicillins; Radiation-Sensitizing Agents | 1984 |
Mechanism of melphalan crosslink enhancement by misonidazole pretreatment.
Topics: Animals; Cell Line; Cricetinae; Cricetulus; DNA; Dose-Response Relationship, Drug; Drug Synergism; Melphalan; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Topics: Animals; Aziridines; Azirines; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Melphalan; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Time Factors | 1984 |
The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
Topics: Animals; Body Temperature; Cell Survival; Cyclophosphamide; Drug Synergism; Female; Half-Life; Kinetics; Male; Melphalan; Mice; Misonidazole; Nitroimidazoles; Time Factors | 1983 |
Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
Topics: Animals; Cross-Linking Reagents; DNA; DNA Repair; DNA, Neoplasm; Fibrosarcoma; Glutathione; Jejunum; Maleates; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Spleen | 1983 |
In vitro inhibition of misonidazole toxicity and melphalan chemopotentiation by metyrapone.
Topics: Animals; Cell Division; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Dexamethasone; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Melphalan; Metyrapone; Misonidazole; Nitroimidazoles; Oxygen | 1983 |
Mechanism of sensitization of Chinese hamster ovary cells to melphalan by hypoxic treatment with misonidazole.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cricetulus; DNA; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutathione; Maleates; Melphalan; Misonidazole; Nitroimidazoles; Ovary; Oxygen | 1983 |
Chemosensitization by lipophilic nitroimidazoles.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Leukocyte Count; Lomustine; Male; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Time Factors | 1983 |
Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
Topics: Animals; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Leukopenia; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Time Factors | 1983 |
Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
Topics: Adult; Aged; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Misonidazole; Neoplasms; Nitroimidazoles | 1983 |
Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chlorambucil; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Lethal Dose 50; Leukocyte Count; Lomustine; Male; Melphalan; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1982 |
Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carmustine; Cell Line; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Melphalan; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Transplantation, Heterologous | 1982 |
Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Topics: Animals; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Lethal Dose 50; Leukocyte Count; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1982 |
Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Dithiothreitol; Dose-Response Relationship, Drug; Drug Synergism; Melphalan; Misonidazole; Nitroimidazoles; Oxygen; Time Factors | 1982 |
Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Male; Melphalan; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles | 1982 |
The interaction of misonidazole with radiation, chemotherapeutic agents, or heat: a preliminary report.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cisplatin; Cricetinae; Hot Temperature; Hypoxia; Mechlorethamine; Melphalan; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
Enhancement of the effect of cytotoxic drugs by radiosensitizers.
Topics: Animals; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Fibrosarcoma; In Vitro Techniques; Melphalan; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Urination | 1981 |
Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
Topics: Alkylating Agents; Animals; Aziridines; Benzoquinones; Cyclohexenes; Cyclophosphamide; Drug Therapy, Combination; Female; Melphalan; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Quinones; Semustine | 1980 |
9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. I.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cisplatin; Cricetinae; Cricetulus; DNA Adducts; DNA, Neoplasm; Drug Synergism; Female; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitroimidazoles; Quinolines; Tumor Cells, Cultured | 1997 |